FDA approves Neuralstem's stem cell trial

09/21/2009 | Chicago Tribune (tiered subscription model)

Neuralstem has received FDA approval to test the safety of injecting neural stem cells into the spinal cords of patients with amyotrophic lateral sclerosis, or Lou Gehrig's disease. Dr. Eva Feldman, a University of Michigan neurologist, will serve as the principal investigator of the clinical trial, which will be conducted at Emory University in Atlanta.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC